# Zoledronic Acid in Acute Spinal Cord Injury

> **NCT01642901** · PHASE3 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 16 (actual)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Zoledronic acid
- **DRUG:** normal saline 0.9%

## Key facts

- **NCT ID:** NCT01642901
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642901, "Zoledronic Acid in Acute Spinal Cord Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01642901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*